Experienced in T-Cell Lymphoma

Dr. Faisal M. Amin

Family Medicine | General Practice
Crescent Wound Care Inc
1310 W Granger Ave, 
Modesto, CA 
Offers Telehealth
17 Years of Experience
Experienced in T-Cell Lymphoma
Crescent Wound Care Inc
1310 W Granger Ave, 
Modesto, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Faisal Amin is a primary care provider, practicing in Family Medicine and General Practice in Modesto, California. Dr. Amin has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Migraine, Headache, Familial Hemiplegic Migraine, Migraine with Brainstem Aura, and Thrombectomy.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of T-Cell Lymphoma.

Graduate Year
2008
Specialties
Family Medicine
General Practice
Licenses
General Practice in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

CRESCENT WOUND CARE INC
1310 W Granger Ave, Modesto, CA 95350

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
View 1 Less Clinical Trial

145 Total Publications

Correction: The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical federation.
Correction: The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical federation.
Journal: The journal of headache and pain
Published: June 16, 2025
Similar Doctors
Experienced in T-Cell Lymphoma
Dr. Yang C. Cao
Family Medicine
Experienced in T-Cell Lymphoma
Dr. Yang C. Cao
Family Medicine

Permanente Medical Group Inc

276 International Cir, 
San Jose, CA 
 (52.4 miles away)
408-972-6931
Experience:
9+ years
Languages Spoken:
English
See accepted insurances

Yang Cao is a primary care provider, practicing in Family Medicine in San Jose, California. Dr. Cao has been practicing medicine for over 9 years and is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Waldenstrom Macroglobulinemia, Gallbladder Cancer, Gallbladder Disease, Gastric Bypass, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Amin's expertise for a condition
ConditionClose
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile